Diagnostics Industry
Filter News
Found 3,188 articles
-
DxTerity Announces a New At-Home COVID-19 Testing Solution
10/19/2020
DxTerity Diagnostics announced the FDA Emergency Use Authorization for their SARS-CoV-2 RT-PCR test, SafeWorkDx™.
-
Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test
10/19/2020
Eurofins U.S. Clinical Diagnostics, announced that Clinical Enterprise Inc. has received an Emergency Use Authorization from the U.S. Food and Drug Administration for their at Home COVID-19 Nasal PCR Test.
-
Castle Biosciences Presents Data on DecisionDx-Melanoma at the Virtual European Association of Dermato-Oncology (EADO) Congress
10/16/2020
Prospective, multi-center study data support use of DecisionDx®-Melanoma in T1-T2 melanoma patients 65 years and older to identify those with a low probability of sentinel lymph node positivity
-
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate Governance Changes In Support of Stakeholder Interests
10/15/2020
Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced that the company has filed its fiscal year 2020 proxy statement and made significant changes to its board structure, executive compensation and corporate governance policies to better serve key company stakeholders.
-
Exact Sciences Selects Veeva Vault Clinical Suite to Help Accelerate Innovation
10/14/2020
Veeva Systems announced that Exact Sciences, a leading provider of cancer screening and diagnostic tests, selected Veeva Vault Clinical Suite to design and run its clinical studies.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020.
-
New Peer-Reviewed Study Demonstrates Ability of HemoScreen For Rapid Evaluation of Acute Leukemia Patients
10/13/2020
Study Shows PixCell's HemoScreen™ May Be Used to Monitor Pathological Blood Samples, Improving Treatment Process for Hematological Patients
-
DECN Provides Progress Update on Major Events for Its GenViro! Saliva Swift Kits for the Detection of COVID-19
10/13/2020
Includes International Distribution Status, Professional Video Finalized, XPRIZE Contest Next Steps, Manufacturing and Signed Testing Partner Updates
-
Castle Biosciences Presents Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
10/12/2020
Presentations highlight DecisionDx-Melanoma and DecisionDx-SCC gene expression profile tests for use in cutaneous melanoma and in cutaneous squamous cell carcinoma
-
Exact Sciences schedules third quarter 2020 earnings call
10/9/2020
Exact Sciences Corp. announced that the company plans to release its third quarter 2020 financial results after the close of the U.S. financial markets on October 29, 2020.
-
Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health
10/7/2020
Todos Medical Ltd. announced that it has entered into an exclusive supply agreement with U.S. national mobile CLIA laboratory company Integrated Health LLC operating MOTOPARA Foundation’s mobile biosafety level 3-built laboratories developed to address the global COVID-19 pandemic.
-
Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement
10/7/2020
Exact Sciences Corp. and Pfizer Inc. announced an extension and amendment of their agreement to promote Cologuard, the first and only FDA-approved non-invasive stool DNA screening test for colorectal cancer.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 6, 2020.
-
Spesana Launches Cancer Treatment Optimization Platform
10/6/2020
The next generation decision-support platform restores an evidence-based approach to molecular diagnostics and oncology
-
Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
10/6/2020
Access SARS-CoV-2 IgG assay shows excellent agreement with surrogate virus neutralization test which identifies antibodies that block the interaction between virus and host cell receptor
-
Castle Biosciences to Present Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
10/6/2020
Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, announced that its data will be featured in oral presentations during the 2020 American Society for Dermatologic Surgery Virtual Annual Meeting, October 9-11, 2020.
-
Diagnostic Robotics and Brown University Center for Digital Innovation to Accelerate AI-Driven Predictive Analytics for Behavioral Health and Patient Triage
10/5/2020
Diagnostic Robotics and the joint Brown University-Lifespan Center for Digital Health announced a new collaboration to accelerate the use of artificial intelligence and machine learning for the delivery of high-quality healthcare.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 2, 2020.
-
DECN Receives Significant Initial Order for International GenViro! Saliva Swift Kits for the Detection of COVID-19
10/2/2020
First Order From Indian Distributor Is Substantially Larger Than Expected, Exceeding International Launch Expectations With Follow-Up Orders From Distributors in Singapore and Malaysia Anticipated
-
Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection
10/2/2020
Co-Diagnostics, Inc. announced that Access Genetics, LLC dba OralDNA® Labs, a CLIA-certified customer who uses the Company's Logix Smart™ COVID-19 kit in their FDA authorized OraRisk® COVID-19 RT-PCR test, recently received an amended Emergency Use Authorization allowing testing from a saline oral rinse collection.